Joel Greenblatt's ALAB Position Overview
Joel Greenblatt (via Gotham Asset Management, LLC) currently holds 4,872 shares of Astera Labs, Inc. (ALAB) worth $810,506, representing 0.00% of the portfolio. First purchased in 2024-Q3, this short-term holding has been held for 5 quarters.
Based on 13F filings, Joel Greenblatt has maintained this position in ALAB for several quarters, showing initial confidence in the investment. Largest addition occurred in Q3 2025, adding 8,664 shares. Largest reduction occurred in Q4 2025, reducing 3,792 shares.
Analysis based on 13F filings available since 2013 Q2
Joel Greenblatt's Astera Labs (ALAB) Holding Value Over Time
Track share changes against reported price movement
Quarterly Astera Labs (ALAB) Trades by Joel Greenblatt
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | -3,792 | Reduce 43.77% | 4,872 | $166.36 |
| Q3 2025 | +8,664 | New Buy | 8,664 | $195.80 |
| Q1 2025 | -2,398 | Sold Out | 0 | $0.00 |
| Q4 2024 | -2,128 | Reduce 47.02% | 2,398 | $132.45 |
| Q3 2024 | +4,526 | New Buy | 4,526 | $52.39 |
Joel Greenblatt's Astera Labs Investment FAQs
Joel Greenblatt first purchased Astera Labs, Inc. (ALAB) in Q3 2024, acquiring 4,526 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Joel Greenblatt has held Astera Labs, Inc. (ALAB) for 5 quarters since Q3 2024.
Joel Greenblatt's largest addition to Astera Labs, Inc. (ALAB) was in Q3 2025, adding 8,664 shares worth $1.7 M.
According to the latest 13F filing for Q4 2025, Joel Greenblatt's firm, Gotham Asset Management, LLC, owns 4,872 shares of Astera Labs, Inc. (ALAB), valued at approximately $810,506.
As of the Q4 2025 filing, Astera Labs, Inc. (ALAB) represents approximately 0.00% of Joel Greenblatt's publicly disclosed stock portfolio, making it one of their key holdings.
Joel Greenblatt's peak holding in Astera Labs, Inc. (ALAB) was 8,664 shares, as reported at the end of Q3 2025.